Ax­some's $570M loan with Black­stone; Al­tim­mune makes its own cred­it deal

Plus, news about Neumo­ra, Eras­ca, Fi­bro­Gen, Tilt Bio­ther­a­peu­tics, Sang­amo, Leap Ther­a­peu­tics, Rem­e­dy Plan, Lex­eo, Karyopharm, Tan­go Ther­a­peu­tics and Hu­ma­cyte:

Ax­some Ther­a­peu­tics gets Black­stone’s help: The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER